1 / 15

Ask the Professor: Hepatitis B and C Clinical Vignettes

Ask the Professor: Hepatitis B and C Clinical Vignettes. The Oregon Gut Club October 2 nd , 2011. Case 1 . 66 year old male with history of NIDDM and obesity. Seen by PCP for 1 month fatigue No history of liver disease or risk factors for viral hepatitis Laboratory studies:

rona
Télécharger la présentation

Ask the Professor: Hepatitis B and C Clinical Vignettes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Ask the Professor:Hepatitis B and C Clinical Vignettes The Oregon Gut Club October 2nd, 2011

  2. Case 1 • 66 year old male with history of NIDDM and obesity. Seen by PCP for 1 month fatigue • No history of liver disease or risk factors for viral hepatitis • Laboratory studies: Tot Bil = 1.1 HAV negative AlkPhos = 130 HBsAgreactive AST = 228 HCV negative ALT = 601 INR = 1.2 plt = 92

  3. Case 1 - continued • Additional Labs HBcAbIgMreactive HBeAgreactive HBeAb negative HBV DNA >170,000,000 IU/mL • Abdominal Ultrasound Liver mildly enlarged with diffuse increased echogenicity. Spleen is normal.

  4. Case 1 - continued • Wait and watch or treat? • After initial consultation with Gastroenterology the patient was seen by cardiology and underwent a coronary angiogram which showed obstructive 3 vessel coronary artery disease. CABG recommended.

  5. Case 2 • 32 year old male from Ghana referred to gastroenterology for hepatitis B • No history of jaundice, encephalopathy, or ascites • Risk factors for chronic viral hepatitis • Country of birth • Blood transfusion at 12 years old • Negative family history for chronic HBV • No history of IVDU

  6. Case 2 - continued • Laboratory studies: • Tbil = 0.5 • AlkPhos = 60 • AST = 41 • ALT = 43 • INR = 1.3 • Plt = 172 • Abdominal US • Normal liver and spleen. No ascites. • HBV DNA 153 million IU/mL • HBeAgreactive

  7. Case 2 - Continued • What Next? • Liver Biopsy • Chronic hepatitis grade 1 stage 2

  8. Case 3 • 30 year old Vietnamese female in second trimester of pregnancy • Referred to GI by her obstetrician for positive hepatitis B surface antigen • Presumed vertical transmission based on family history • No history of jaundice, ascites, encephalopathy, or GIB

  9. Case 3 - continued • Laboratory Studies • Tbil = 0.2 • AlkPhos = 43 Liver Biopsy 1 year prior • AST = 23 Grade 1 Stage 1 • ALT = 33 • Plt = 220 • INR = 1.0 • HBV DNA 89,000 IU/mL • HBeAgpositive

  10. Case 4 – second opinion • 32 year old Chinese femalewith a history of chronic HBV diagnosed after emigrating to the United states. • Presumed vertical transmission • No history of liver ascites/encephalopathy/GIB • Referred to GI in 2006 • ALT = 195 AST =99 • HBeAgpositive • HBV DNA 19,400,000 IU/mL Genotype C

  11. Case 4 - Continued • Several months later was found to be HBeAg negative and HBeAbpositive. • Started on Entecavir due to rising transaminases • Liver tests normalized and HBV became undetectable within 6 months. • Labs have remained normal for 2 years. • Most recent studies • HBsAgpositive, HBeAb positive, HBV DNA neg, ALT =16

  12. Case 4 - continued • Next step? • Wait for surface antigen loss or stop Entacavir?

  13. Case 5 • 63 year male with Chronic HCV, genotype 1, diagnosed in 2004 • No history of ascites, encephalopathy, or GIB • Liver biopsy 3/3/04 showed grade 1, stage 1 disease • Developed acute renal failure with nephrotic range proteinuria and anasarca in 2011. Kidney biopsy showed glomerular changes suggestive of possible membranoproliferative glomerulonephritis • Started on plasmapheresis and sent to GI for possible HCV treatment

  14. Case 5 - continued • Pertinent laboratory studies • HCV PCR 1,710,000 IU/mL • Tbil = 0.2 • AlkPhos = 62 • ALT = 18 C3 = 67 L • AST = 20 C4 = 27 RF = <10 • Plt = 204 Cryoglobulin = neg • INR = 1.1 • Creat = 2.0

  15. Case 6 • 35 year female with history of heavy alcohol use, depression with active suicidal ideation, and chronic HCV genotype 1. • Biopsy in 2010: Grade 2 Stage 3 disease. • Therapy deferred in 2010 due to poor social support, mental illness, and ongoing alcohol use. • Now sober for 1 year and returns to clinic to discuss the “new” hepatitis C medications.

More Related